Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) EBT Margin (2012 - 2026)

Updated

Oncotelic Therapeutics' EBT Margin was -464.74% in Q2 2026.

Analysis

Oncotelic Therapeutics (OTLC) EBT Margin (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Oncotelic Therapeutics' EBT Margin was -1424.32% through Jun 30, 2026; for FY2023, it came in at -10989.72%.

  • EBT Margin shows a three-year change of -10439.24 percentage points (FY2020 to FY2023).
  • In earlier years, EBT Margin was -2225.74% in FY2021 (-1675.26 pp) and -550.48% in FY2020.
  • The Q2 2026 figure marks the highest quarterly EBT Margin since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,147.31 Bn 1,115.89 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 622.41 Bn 540.94 Bn 17.26 Bn 26.66%
3 AbbVie 509.04 Bn 482.15 Bn 12.70 Bn 25.18%
4 Merck 365.25 Bn 319.63 Bn 12.21 Bn -4.11%
5 Novartis Ag 297.40 Bn 261.39 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.42 Bn 235.10 Bn 12.86 Bn 18.19%
7 Amgen 235.41 Bn 190.81 Bn 7.24 Bn 27.53%
8 Gilead Sciences 193.83 Bn 168.03 Bn 6.22 Bn -131.41%
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -4.34%
10 Oncotelic Therapeutics 8.05 Mn 7.20 Mn - -464.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -464.74%
Sep 30, 2023 -244.21%
Mar 31, 2021 -511.76%
Jun 30, 2020 -8.80%
Mar 31, 2020 -1,113.96%
Sep 30, 2013 -2,785.26%
Dec 31, 2012 -3,973.81%
Mar 31, 2012 -1,649.12%
API Access

Oncotelic Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=OTLC&period=max&api_key=YOUR_API_KEY